Coverage with Evidence Development, Only in Research, Risk Sharing, or Patient Access Scheme? A Framework for Coverage Decisions

A range of decision options may facilitate paying for the use of promising medical technologies despite their uncertain evidence. It is important that the option be chosen on the basis of not only the expected value of a technology but also the value of further research, the anticipated effect of coverage on further research, and the costs associated with reversing the decision.